CT scan not necessary to diagnose cancer in patients with unexplained blood clots
the ONA take:
According to a new study published in the New England Journal of Medicine, researchers have found that a CT scan of the abdomen and pelvis does not improve cancer detection in people with unexplained deep vein thromboemboli and pulmonary emboli.
For the study, researchers enrolled 854 patients with unexplained blots in the legs, lungs, or both. Patients were randomly assigned to receive basic cancer screening with or without a CT scan of the abdomen and pelvis.
Basic cancer screening involved laboratory blood tests, a chest x-ray, and if applicable, a breast exam, prostate exam, or pap smear.
Results showed there was no difference in the incidence of new cancers between the two groups. Researchers found that about 4% of each group was diagnosed with cancer within the next year.
The study also demonstrated no difference in the number of cancer-related deaths between the two treatment arms.
The findings are expected to ultimately improve patient care and lower screening costs globally.
CT scan of the abdomen and pelvis does not improve cancer detection in people with unexplained deep vein thromboemboli.
Sign Up for Free e-newsletters
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Identifying the Psychosocial Needs of Young Adults With Metastatic Cancer
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- Partial Response Achieved With Atezolizumab, Cobimetinib in Pretreated CRC
- Novel Approach Can Improve Both Colorectal Cancer Screening Outcomes and Adherence
- Survival Outcomes in Relapsed Hepatocellular Carcinoma Improved With Cabozantinib
- OS Similar With Gemcitabine Plus S-1 vs Standard Therapy for Biliary Tract Cancer
- Feasibility and Outcomes of Modified Enhanced Recovery After Surgery for Nursing Management of Aged Patients Undergoing Esophagectomy
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|